Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
My Chef sells home meal kits.
PharmCADD uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design.
The Check is a mobile application that offers card sales settlement, electronic labor contracts and real-time VAT inquiry services.
Oncocross is a Biopharmaceutical Company.
Nature Gluetech develops mass production technology and commercialization technology for bioadhesives.
APITBIO is a biotech company that specializes in antibody therapeutics research and development.
URBAN Digital Marketing is a full-service digital marketing firm.
LISCure Biosciences is a biotech company that researches and develops bacteria-mediated immunotherapy.
House of Rebels is an IP-commerce group holding culture-based media and brands.
BiSiChem is a biotechnology company that focuses on the drug discovery and development field.
Stayes is an online platform that helps users to plan and live in South Korea.
KB Securities has invested in 59 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
KB Securities's top investment sectors include Biotechnology, Pharmaceutical, Health Care, Biopharma, Advertising. The firm invests across 22 different industry categories.
Among tracked funding rounds, PharmCADD received $16.0M in a Series B round. KB Securities's total known invested capital is $308.1M.
KB Securities's average investment size is $8.3M across its portfolio of 59 companies.
Recent KB Securities portfolio additions include My Chef, PharmCADD, The Check, Oncocross, Nature Gluetech. These companies were founded in 2020 or later.